From the Fourth Department of Internal Medicine, Silesian University, Scool of Medicine, ul. Edukacji 102, PL 43-100 Tychy, Poland.
Abstract: (3374 Views)
Rats were treated with acetylsalicylic acid (150 mgikg b.w.per os daily)
or naproxen (125 mg/kg b.w. per os daily) for six weeks. Half of the rats
received silymarin (17.5 mgikg b.w. per os daily) in the last three weeks of
the experiment. It was found tliat administration of acetylsalicylic acid led to
signs of hepatic damage (an increase in serum bilirubin level, alanine aminotransferase
and ү-glutamyl transpeptidase activity) while the concomitant
administration of silymarin diminished the extent of the hepatic damage.
Naproxen was shown to be less toxic than acetylsalicylic acid, and its toxicity
was also reduced by silymarin. The obtained results suggest that
silymarin be administered to patients undergoing long-term treatment with
non-steroidal anti-inflammatory drugs in order to prevent hepatic damage,
but further studies are needed to elaborate on the clinical aspects of
silymarin treatment in those patients.